The following discussion of our consolidated results of operations and cash
flows for the nine months ended September 30, 2021 and 2020, and consolidated
financial conditions as of September 30, 2021 and December 31, 2020 should be
read in conjunction with our unaudited consolidated financial statements and the
related notes included elsewhere in this document.



Overview



We are a major grower and seller of yew trees and manufacturer of products made
from yew trees, we also sell branches and leaves of yew trees for the
manufacture of TCM containing taxol, which TCM has been approved in the PRC for
use as a secondary treatment of certain cancers, meaning it must be administered
in combination with other pharmaceutical drugs. The yew industry is highly
regulated in the PRC because the Northeast yew tree is considered an endangered
species. In the third quarter of 2016, we started to sell handmade yew essence
oil soaps and candles.



We operated in two reportable business segments. The business of HDS, JSJ, HYF
and YBT in PRC was managed and reviewed as PRC segment. The business of YBP, Yew
Bio-Pharm (HK), and MC was managed and reviewed as USA segment.



For the three months ended September 30, 2021 and 2020, revenues from the PRC segment accounted for approximately 99.17% and 99.84%, respectively, of consolidated revenue; revenues from USA segment accounted for approximately 0.83% and 0.16% of consolidated revenue.

For the nine months ended September 30, 2021 and 2020, revenues from the PRC segment accounted for approximately 99.94% and 99.82%, respectively, of consolidated revenue; revenues from USA segment accounted for approximately 0.06% and 0.18% of consolidated revenue.





YBP's revenues were mostly generated by HDS and in the PRC. The expenses
incurred in the U.S. were primarily related to fulfilling the reporting
requirements of public listed company, stock-based compensation, office daily
operations and other costs. As of September 30, 2021, YBP had $100 in cash and
held the 100% equity interests in its subsidiaries Yew HK and JSJ. Yew HK itself
has no business operations or assets other than holding of equity interests in
JSJ. JSJ has no business operations and assets with a book value of
approximately $9,111, including approximately $9,111 in cash on September 30,
2021. JSJ also holds the VIE interests in HDS through the contractual
arrangements (the "Contractual Arrangements") described in Notes to Unaudited
Consolidated Financial Statements. On November 4, 2014, HDS established a new
subsidiary, Harbin Yew Food Co. LTD. ("HYF"), to develop and cultivate wood ear
mushroom drink. As of September 30, 2021, HYF had started pilot production with
a limited amount of sales. On December 24, 2020, HDS acquired 80% ownership of a
new subsidiary, Yew (Guangzhou) Bio-Technology Co., Ltd ("YBT"), to marketing
and sell cosmetics. As of September 30, 2021, YBT had not started sales. In the
event that we are unable to enforce the Contractual Agreements, we may not be
able to exert effective control over HDS, HYF and YBT, and our ability to
conduct our business may be materially and adversely affected. If the applicable
PRC authorities invalidate our Contractual Agreements for any violation of PRC
laws, rules and regulations, we would lose control of the VIE and its subsidiary
resulting in its deconsolidation in financial reporting and severe loss in our
market valuation. On June 8, 2016, YBP established a new subsidiary, MC Commerce
Holding Inc. (MC), to sales the Company's yew products in American market. MC
had limited operation activities for the nine months ended September 30, 2021.



In December 2019, COVID-19 was reported in China. Since then, COVID-19 has
spread globally, to include the United States and several European countries.
Many countries around the world have imposed quarantines and restrictions on
travel and mass gatherings to slow the spread of the virus and have closed
non-essential businesses. The pandemics could result in increased travel
restrictions, market downturns and changes in the behavior of the terminal
customers of our products related to pandemic fears. In addition, our certain
customers could decrease the demand on our products due to the outbreak of the
COVID-19. To date, our business is impact by the outbreak of the coronavirus
(COVID-19) in China. The extent to which the coronavirus impacts our results
will depend on future developments and reactions in China, which are highly
uncertain and will include emerging information concerning the severity of the
coronavirus and the actions taken by governments to attempt to contain the
coronavirus. Any decreased collectability of accounts receivable, or reduction
of purchase orders could further negatively impact our results of operations.



Critical accounting policies and estimates





Our discussion and analysis of our financial condition and results of operations
are based upon our consolidated financial statements, which have been prepared
in accordance with accounting principles generally accepted in the United
States. The preparation of these consolidated financial statements requires us
to make estimates and judgments that affect the reported amounts of assets,
liabilities, revenues and expenses, and related disclosure of contingent assets
and liabilities. We continually evaluate our estimates, including those related
to bad debts, allowance for obsolete inventory, and the classification of short
and long-term inventory, the useful life of property and equipment and land use
rights and yew forest assets, recovery of long-lived assets, write-down in value
of inventory, and the valuation of equity transactions. We base our estimates on
historical experience and on various other assumptions that we believed to be
reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. Any future changes to these estimates
and assumptions could cause a material change to our reported amounts of
revenues, expenses, assets and liabilities. Actual results may differ from these
estimates under different assumptions or conditions. We believe the following
critical accounting policies affect our significant judgments and estimates used
in the preparation of the financial statements.



  21







Variable interest entities



Pursuant to ASC 810 and related subtopics related to the consolidation of
variable interest entities, we are required to include in our consolidated
financial statements the financial statements of VIEs. The accounting standards
require a VIE to be consolidated by a company if that company is subject to the
risk of loss for the VIE or is entitled to receive the VIE's residual returns.
VIEs are those entities in which we, through contractual arrangements, bear the
risk of, and enjoy the rewards normally associated with ownership of the entity,
and therefore we are the primary beneficiary of the entity. HDS is considered a
VIE, and we are the primary beneficiary. We entered into agreements with HDS
pursuant to which we shall receive 100% of HDS's net income. In accordance with
these agreements, HDS shall pay consulting fees equal to 100% of its net income
to our wholly-owned subsidiary, JSJ. JSJ shall supply the technology and
administrative services needed to service the HDS.



The accounts of HDS are consolidated in the accompanying financial statements.
As a VIE, HDS' sales are included in our total sales, its income from operations
is consolidated with ours, and our net income includes all of HDS' net income,
and their assets and liabilities are included in our consolidated balance
sheets. The VIEs do not have any non-controlling interest and, accordingly, we
did not subtract any net income in calculating the net income attributable to
us. Because of the contractual arrangements, we have pecuniary interest in HDS
that requires consolidation of HDS' financial statements with our financial
statements.



As required by ASC 810-10, we perform a qualitative assessment to determine
whether we are the primary beneficiary of HDS which is identified as a VIE of
us. A quality assessment begins with an understanding of the nature of the risks
in the entity as well as the nature of the entity's activities including terms
of the contracts entered into by the entity, ownership interests issued by the
entity and the parties involved in the design of the entity. The significant
terms of the agreements between us and HDS are discussed above in the "Corporate
Structure and Recapitalization - Second Restructure" section. Our assessment on
the involvement with HDS reveals that we have the absolute power to direct the
most significant activities that impact the economic performance of HDS. JSJ,
our wholly own subsidiary, is obligated to absorb the risk of loss from HDS
activities and is entitled to receive HDS's expected residual returns. In
addition, HDS' shareholders have pledged their equity interest in HDS to JSJ,
irrevocably granted JSJ an exclusive option to purchase, to the extent permitted
under PRC Law, all or part of the equity interests in HDS and agreed to entrust
all the rights to exercise their voting power to the person(s) appointed by JSJ.
Under the accounting guidance, we are deemed to be the primary beneficiary of
HDS and the results of HDS' operation are consolidated in our consolidated
financial statements for financial reporting purposes.



Accordingly, as a VIE, HDS' sales are included in our total sales, its income
from operations is consolidated with our income from operations and our net
income includes all of HDS' net income. All the equity (net assets) and profits
(losses) of HDS are attributed to us. Therefore, no non-controlling interest in
HDS is presented in our consolidated financial statements. As we do not have any
non-controlling interest and, accordingly, did not subtract any net income in
calculating the net income attributable to us. Because of the Contractual
Arrangements, YBP has a pecuniary interest in HDS that requires consolidation of
HDS' financial statements with those of ours.



Additionally, pursuant to ASC 805, as YBP and HDS are under the common control
of the HDS Shareholders, the Second Restructure was accounted for in a manner
similar to a pooling of interests. As a result, our historical amounts in the
accompanying consolidated financial statements give retrospective effect to the
Second Restructure, whereby our assets and liabilities are reflected at the
historical carrying values and their operations are presented as if they were
consolidated for all periods presented, with our results of operations being
consolidated from the date of the Second Transfer Agreement. The accounts of HDS
are consolidated in the accompanying financial statements.



Accounts receivable



Accounts receivable are presented net of an allowance for doubtful accounts. We
maintain allowances for doubtful accounts for estimated losses. We review the
accounts receivable balance on a periodic basis and make general and specific
allowances when there is doubt as to the collectability of individual balances.
In evaluating the collectability of individual receivable balances, we consider
many factors, including the age of the balance, a customer's historical payment
history, its current credit-worthiness and current economic trends. Accounts are
written off after exhaustive efforts at collection. We recognize the probability
of the collection for each customer.



Inventories



Inventories consisted of raw materials, work-in-progress, finished
goods-handicrafts, yew seedlings, yew candles and other trees (consisting of
larix, spruce and poplar trees). We classify our inventories based on our
historical and anticipated levels of sales; any inventory in excess of its
normal operating cycle of one year is classified as long-term on our
consolidated balance sheets. Inventories are stated at the lower of cost or
market value utilizing the weighted average method. Raw materials primarily
include yew timber used in the production of products such as handicrafts,
furniture and other products containing yew timber. Finished goods-handicraft
and yew seedlings include direct materials and direct labor.



We estimate the amount of the excess inventories by comparing inventory on hand
with the estimated sales that can be sold within our normal operating cycle of
one year. Any inventory in excess of our current requirements based on
historical and anticipated levels of sales is classified as long-term on our
consolidated balance sheets. Our classification of long-term inventory requires
us to estimate the portion of inventory that can be realized over the next

12
months.



  22







To estimate the amount of slow-moving or obsolete inventories, we analyze
movement of our products, monitor competing products and technologies and
evaluate acceptance of our products. Periodically, we identify inventories that
cannot be sold at all or can only be sold at deeply discounted prices. An
allowance will be established if management determines that certain inventories
may not be saleable. If inventory costs exceed expected market value due to
obsolescence or quantities in excess of expected demand, we will record reserves
for the difference between the carrying cost and the estimated market value.



Our handicraft and yew furniture products are hand-made by traditional Chinese artisans.





In accordance with ASC 905, "Agriculture", our costs of growing yew seedlings
are accumulated until the time of harvest and are reported at the lower of

cost
or market.



Property and equipment



Property and equipment are carried at cost and are depreciated on a
straight-line basis (after taking into account their respective estimated
residual value) over the estimated useful lives of the assets. The cost of
repairs and maintenance is expensed as incurred; major replacements and
improvements are capitalized. When assets are retired or disposed of, the cost
and accumulated depreciation are removed from the accounts, and any resulting
gains or losses are included in income in the year of disposition. We examine
the possibility of decreases in the value of fixed assets when events or changes
in circumstances reflect the fact that their recorded value may not be
recoverable. The estimated useful lives are as follows:



Building                  10 - 20 years
Machinery and equipment    3 - 10 years
Office equipment            2 - 5 years
Motor vehicles             4 - 10 years



Land use rights and yew forest assets





All land in the PRC is owned by the PRC government and cannot be sold to any
individual or company. We have recorded the amounts paid to the PRC government
to acquire long-term interests to utilize land and yew forests as land use
rights and yew forest assets. This type of arrangement is common for the use of
land in the PRC. Yew trees on land containing yew tree forests are used to
supply raw materials such as branches, leaves and fruit to us that will be used
to manufacture our products. We amortize these land and yew forest use rights
over the term of the respective land and yew forest use right, which ranges from
15 to 50 years. The lease agreements do not have any renewal option and we have
no further obligations to the lessor. We record the amortization of these land
and forest use rights as part of our cost of revenues.



Revenue recognition



We generate our revenue from sales of yew seedling products, sales of yew raw
materials for medical application, sales of yew handicraft products, sales of
"Others" including yew candles, yew essential oil soap, pine needle extract,
complex taxus cuspidate extract, and composite northeast yew extract. Pursuant
to the guidance of ASC 606, we recognize revenue when obligations under the
terms of a contract with customer are satisfied; generally this occurs with the
transfer of control of the products sold. Transfer of control to the customer is
based on the standardized shipping terms in the contract as this determines when
we has the right to payment, the customer has legal title to the asset and the
customer has the risks of ownership.



Income taxes



We are governed by the Income Tax Law of the PRC, Hong Kong and the United
States. We account for income tax using the liability method prescribed by ASC
740, "Income Taxes". Under this method, deferred tax assets and liabilities are
determined based on the difference between the financial reporting and tax bases
of assets and liabilities using enacted tax rates that will be in effect in the
year in which the differences are expected to reverse. We record a valuation
allowance to offset deferred tax assets if based on the weight of available
evidence; it is more-likely-than-not that some portion, or all, of the deferred
tax assets will not be realized. The effect on deferred taxes of a change in tax
rates is recognized as income or loss in the period that includes the enactment
date.



 We apply the provisions of ASC 740-10-50, "Accounting for Uncertainty in Income
Taxes", which provides clarification related to the process associated with
accounting for uncertain tax positions recognized in our financial statements.
Audit periods remain open for review until the statute of limitations has
passed. The completion of review or the expiration of the statute of limitations
for a given audit period could result in an adjustment to our liability for
income taxes. Any such adjustment could be material to our results of operations
for any given quarterly or annual period based, in part, upon the results of
operations for the given period. Currently, we have no uncertain tax positions,
and will continue to evaluate for uncertain positions in the future.



  23







Stock-based compensation



Stock based compensation is accounted for based on the requirements of the
Share-Based Payment topic of ASC 718 which requires recognition in the financial
statements of the cost of employee and director services received in exchange
for an award of equity instruments over the period the employee or director is
required to perform the services in exchange for the award. The Accounting
Standards Codification also requires measurement of the cost of employee and
director services received in exchange for an award based on the grant-date

fair
value of the award.



The Company accounts for share-based compensation awards to nonemployees in
accordance with FASB ASC 718 and FASB ASC 505-50. Under FASB ASC 718 and FASB
ASC 505-50, stock compensation granted to non-employees has been determined as
the fair value of the consideration received or the fair value of equity
instrument issued, whichever is more reliably measured and is recognized as an
expense as the goods or services are received.



Recent accounting pronouncements


In February 2016, the Financial Accounting Standards Board ("FASB") issued new
leasing guidance ("Topic 842") that replaced the existing lease guidance ("Topic
840"). Topic 842 established a right-of-use ("ROU") model that requires a lessee
to record a ROU asset and lease liability on the balance sheet for all leases
with terms longer than 12 months. Leases are classified as either finance or
operating, with classification affecting the pattern of expense recognition in
the statement of operations. This guidance also expanded the requirements for
lessees to record leases embedded in other arrangements and the required
quantitative and qualitative disclosures surrounding leases.



The Company adopted Topic 842 on its effective date of January 1, 2019 using a
modified retrospective transition approach; as such, Topic 842 will not be
applied to periods prior to adoption and the adoption had no impact on the
Company's previously reported results. The Company elected the package of
practical expedients permitted under the transition guidance within Topic 842,
which allowed the Company to carry forward its identification of contracts that
are or contain leases, its historical lease classification and its accounting
for initial direct costs for existing leases. The impact of adopting Topic 842
was not material to the Company's result of operations or cash flows for the
nine months ended September 30, 2021. The Company recognized operating lease
liabilities of $350,000 upon adoption, with corresponding ROU assets on its

balance sheet.



Currency exchange rates



Our functional currency is the U.S. dollar, and the functional currency of our
operating subsidiaries and VIE is the RMB. All of our sales are denominated in
RMB. As a result, changes in the relative values of U.S. dollars and RMB affect
our reported levels of revenues and profitability as the results of our
operations are translated into U.S. dollars for reporting purposes. In
particular, fluctuations in currency exchange rates could have a significant
impact on our financial stability due to a mismatch among various foreign
currency-denominated sales and costs. Fluctuations in exchange rates between the
U.S. dollar and RMB affect our gross and net profit margins and could result in
foreign exchange and operating losses.



Our exposure to foreign exchange risk primarily relates to currency gains or
losses resulting from timing differences between signing of sales contracts and
settling of these contracts. Furthermore, we translate monetary assets and
liabilities denominated in other currencies into RMB, the functional currency of
our operating subsidiaries. Our results of operations and cash flow are
translated at average exchange rates during the period, and assets and
liabilities are translated at the unified exchange rate at the end of the
period. Translation adjustments resulting from this process are included in
accumulated other comprehensive income in our statement of shareholders' equity.
We have not used any forward contracts, currency options or borrowings to hedge
our exposure to foreign currency exchange risk. We cannot predict the impact of
future exchange rate fluctuations on our results of operations and may incur net
foreign currency losses in the future.



Our financial statements are expressed in U.S. dollars, which is the functional
currency of our parent company. The functional currency of our operating
subsidiaries and affiliates is RMB. To the extent we hold assets denominated in
U.S. dollars, any appreciation of the RMB against the U.S. dollar could result
in a charge in our statement of operations and a reduction in the value of our
U.S. dollar denominated assets. On the other hand, a decline in the value of RMB
against the U.S. dollar could reduce the U.S. dollar equivalent amounts of

our
financial results.



  24







Results of Operations



The following tables set forth key components of our results of operations for
the periods indicated, in dollars. The discussion following the table is based
on these results:



                                                Three Months Ended                 Nine Months Ended
                                                   September 30,                     September 30,
                                               2021             2020             2021             2020
Revenues - third parties                   $          -     $    498,346     $  6,804,702     $    679,844
Revenues - related parties                      110,106        9,856,869       16,886,287       21,266,710
Total revenues                                  110,106       10,355,215       23,690,989       21,946,554
Cost of revenues - third parties                  2,814          463,359        6,948,445          845,929
Cost of revenues - related parties              947,360        8,366,498       16,853,667       17,847,629
Total cost of revenues                          950,174        8,829,857   

   23,802,112       18,693,558
Gross profit                                   (840,068 )      1,525,358         (111,123 )      3,252,996
Operating expenses                              718,200           31,180       (1,088,921 )        744,930

Income from operations                       (1,558,268 )      1,494,178          977,798        2,508,066
Other expenses, net                                (426 )       (471,052 ) 

     (170,264 )       (595,961 )
Income taxes                                          -          (27,152 )         (1,859 )        (27,152 )
Net income                                   (1,558,694 )        995,974          805,675        1,884,953
Other comprehensive income (loss):
Foreign currency translation adjustment          39,056        1,671,103          510,185          957,348
Comprehensive income (loss)                $ (1,519,638 )   $  2,667,077
 $  1,315,860     $  2,842,301




  25






Three and Nine Months Ended September 30, 2021 Compared to Three and Nine Months Ended September 30, 2020





Revenues



For the three months ended September 30, 2021, we had total revenues of
$110,106, as compared to $10,355,215 for the three months ended September 30,
2020, a decrease of $10,245,109 or 98.94%. The decrease in total revenue was
attributable to the decrease in revenues of extracts and TCM raw materials.



For the nine months ended September 30, 2021, we had total revenues of
$23,690,989, as compared to $21,946,554, for the nine months ended September 30,
2020, an increase of $ 1,744,435 or 7.95%. The increase in total revenue was
attributable to the increase in revenues of extracts which was partially offset
by the decrease in revenues of TCM raw materials.



Total revenue is summarized as follows:





                       Three Months Ended
                          September 30,              Increase        Percentage
                      2021            2020          (Decrease)         Change
TCM raw materials   $       -     $  6,844,205     $  (6,844,205 )       (100.00 )%
Handicrafts           114,296            9,599           104,697        1,090.71 %
Extracts                    -        3,482,058        (3,482,058 )       (100.00 )
Others                 (4,190 )         19,353           (23,543 )       (121.65 )%
Total               $ 110,106     $ 10,355,215     $ (10,245,109 )        (98.94 )%






                          Nine Months Ended
                            September 30,               Increase       Percentage
                        2021             2020          (Decrease)        Change
TCM raw materials   $  9,935,074     $ 13,927,843     $ (3,992,769 )        (28.67 )%
Handicrafts              114,296            9,599          104,697        1,090.71 %
Extracts              13,575,521        7,808,261        5,767,259           73.86
Others                    66,098          200,851         (134,752 )        (67.09 )%
Total               $ 23,690,989     $ 21,946,554     $  1,744,435            7.95 %






For the three months ended September 30, 2021 compared to September 30, 2020,
the decrease in extracts was mainly attributable to the decrease in demand of
pine needle extract, complex taxus cuspidate extract, and composite northeast
yew extract. The decrease in revenue of TCM raw material was mainly attributable
to the decrease in demand from our related party, Yew Pharmaceutical.



For the nine months ended September 30, 2021 compared to September 30, 2020, the
increase in extracts was mainly attributable to the increase in demand of pine
needle extract, complex taxus cuspidate extract, and composite northeast yew
extract. The decrease in revenue of TCM raw material was mainly attributable to
the decrease in demand from our related party, Yew Pharmaceutical.



Cost of Revenues



For the three months ended September 30, 2021, cost of revenues amounted to
$950,174 as compared to $8,829,857 for the three months ended September 30,
2020, a decrease of $7,879,683 or 89.24%. For the three months ended September
30, 2021, cost of revenues accounted for 862.964% of total revenues compared to
85,27% of total revenues for the three months ended September 30, 2020.



For the nine months ended September 30, 2021, cost of revenues amounted to
$23,802,112 as compared to $18,693,558 for the nine months ended September 30,
2020, an increase of $5,108,554 or 27.33%. For the nine months ended September
30, 2021, cost of revenues accounted for 100.47% of total revenues compared to
85.17% of total revenues for the nine months ended September 30, 2020.



  26






Cost of revenues by product categories is as follows:





                        Three Months Ended
                           September 30,              Increase       Percentage
                       2021            2020          (Decrease)        Change
TCM raw materials   $  (707,858 )   $ 5,255,828     $ (5,963,686 )       (113.47 )%
Handicrafts             111,001           9,452          101,550        1,074.41 %
Extracts                 (2,899 )     3,647,661       (3,650,560 )       (100.08 )
Others                1,549,930         (83,084 )      1,633,014       (1,965.50 )%
Total               $   950,174     $ 8,829,857     $ (7,879,683 )        (89.24 )%




                          Nine months Ended
                            September 30,               Increase       Percentage
                        2021             2020          (Decrease)        Change
TCM raw materials   $  8,500,022     $ 10,825,135     $ (2,325,113 )        (21.48 )%
Handicrafts              111,001            9,452          101,550        1,074.41 %
Extracts              13,395,265        7,497,537        5,897,728           78.66
Others                 1,795,823          361,434        1,434,389          396.86 %
Total               $ 23,802,112     $ 18,693,558     $  5,108,554           27.33 %




The decrease and increase in our cost of revenues for the three and nine months
ended September 30, 2021 as compared to the three months and nine months ended
September 30, 2020 were in line with the increase in revenue.



Gross Profit



For the three months ended September 30, 2021, gross profit was $(840,068) as
compared to $1,525,358 for the three months ended September 30, 2020,
representing gross profit margins of (762.96)% and14.73%, respectively. For the
nine months ended September 30, 2021, gross profit was $(111,123) as compared to
$3,252,996 for the nine months ended September 30, 2020, representing gross
profit margins of (0.47)% and 14.82%, respectively. Gross profit margins by
categories are as follows:



                                                Three Months Ended                                Nine months Ended
                                                  September 30,                                     September 30,
                                                                    (Decrease)                                       (Decrease)
                                      2021             2020          Increase            2021            2020         Increase
TCM raw materials                    (32.823.62 )%      23.21 %       (32,846.83 )%         14.44 %       22.28 %          (7.84 )%
Handicrafts                                2.88 %        1.54 %             1.34 %           2.88 %        1.54 %           1.34 %
Extracts                                   1.33 %       (4.76 )%            6.09 %           1.33 %        3.98 %          (2.65 )%
Others                              (172.442.63 )%     529.32 %      (172,971.95 )%     (2,616.90 )%     (79.95 )%     (2,536.95 )%
Total                                   (762.96 )%      14.73 %          (777.69 )%         (0.47 )%      14.82 %         (15.29 )%




The decrease in our overall gross profit margin for the three and nine months
ended September 30, 2021 as compared to the three and nine months ended
September 30, 2020 were primarily attributable to the lower gross margin yields
of TCM raw materials.



  27







Operating Expenses



For the three months ended September 30, 2021, operating expenses amounted to
$718,200, as compared to $31,180 for the three months ended September 30, 2020,
an increase of $687,020 or 2203.4%. The increase was mainly due to the bad debt
expense occurred during the three months ended September 30, 2021, compares with
the bad debt recovery occurred during the three months ended September 30, 2020.



For the nine months ended September 30, 2021, operating expenses amounted to
$(1,088,921) as compared to $744,930 for the nine months ended September 30,
2020, a decrease of $1,833,851 or 246.18%. The decrease was mainly due to the
bad debt recovery occurred during the nine months ended September 30, 2021,
compares with the bad debt expense occurred during the nine months ended
September 30, 2020.



Income from Operations


For the three months ended September 30, 2021, income from operations was $(1,558,268), as compared to income from operations of $1,494,178 for the three months ended September 30, 2020, a decrease of $3,052,446, or 204.29%. The decrease was primarily attributable to the decrease in gross profit and the increase of bad debt expenses.

For the nine months ended September 30, 2021, income from operations was $977,798, as compared to income from operations of $2,508,066 for the nine months ended September 30, 2020, a decrease of $1,530,268, or 61.01%. The decrease was primarily attributable to decrease in gross profit after offset by the decrease of bad debt expenses.





Other Expenses



For the three months ended September 30, 2021, total other expense was $426 as
compared to total other expense of $471,052 for the three months ended September
30, 2020. The decrease was primarily attributable to the increase of other
income and exchange gain.



For the nine months ended September 30, 2021, total other expense was $170,264
as compared to total other expense of $595,561 for the nine months ended
September 30, 2020. The decrease was primarily attributable to the increase of
other income, and the decrease of exchange loss.



Net Income



As a result of the factors described above, our net income was $(1,558,694) or
$(0.03) (basic and diluted), for the three months ended September 30, 2021, as
compared to net income of $995,974 or $0.02 (basic and diluted), for the three
months ended September 30, 2020. As a result of the factors described above, our
net income was $805,675 or $0.02 (basic and diluted), for the nine months ended
September 30, 2021, as compared to net income of $1,884,953 or $0.04 (basic and
diluted), for the nine months ended September 30, 2020.



Foreign Currency Translation Adjustment





For the three months ended September 30, 2021, we reported an unrealized gain on
foreign currency translation of $39,056, as compared to an unrealized gain of
$1,671,103 for the three months ended September 30, 2020. For the nine months
ended September 30, 2021, we reported an unrealized gain on foreign currency
translation of $510,185, as compared to an unrealized gain of $957,348 for the
nine months ended September 30, 2020. The change reflects the effect of the
value of the U.S. dollar in relation to the RMB. As described elsewhere herein,
the functional currency of our subsidiary, JSJ, and our VIE, HDS, is the RMB.
The accompanying consolidated financial statements have been translated and
presented in U.S. dollars using period end rates of exchange for assets and
liabilities, and average rates of exchange for the period for net revenues,
costs, and expenses. Net gains resulting from foreign exchange transactions, if
any, are included in the consolidated statements of income and comprehensive
income.



Comprehensive Income



For the three months ended September 30, 2021, comprehensive income of
$(1,519,638) was derived from the sum of our net income of $(1,558,694) with
foreign currency translation gain of $39,056. For the three months ended
September 30, 2020, comprehensive income of $2,667,077 was derived from the sum
of our net income of $995,974 with foreign currency translation gain of
$1,671,103.



For the nine months ended September 30, 2021, comprehensive income of $1,315,860
was derived from the sum of our net income of $805,675 with foreign currency
translation gain of $510,185. For the nine months ended September 30, 2020,
comprehensive income of $2,842,301 was derived from the sum of our net income of
$1,884,953 with foreign currency translation gain of $957,348.



Segment Information



For the three and nine months ended September 30, 2021 as compared to the three
and nine months ended September 30, 2020, we operated in two reportable business
segments. The business of HDS, JSJ, HYF and YBT in PRC was managed and reviewed
as PRC segment. The business of YBP, Yew Bio-Pharm (HK), and MC was managed

and
reviewed as USA segment.



  28






Information with respect to these reportable business segments for the three months ended September 30, 2021 and 2020 was as follows:





                                              For the three months                           For the three months
                                               September 30, 2021                             September 30, 2020
                                    Revenues-       Revenues -                    Revenues-      Revenues -
                                      third          related                        third          related
                                     parties          party           Total        parties          party           Total
Revenues:
PRC                                $    (1,470 )   $    110,666     $ 109,196     $  481,661     $ 9,856,869     $ 10,338,530

USA                                        910                -           910         16,685               -           16,685

Total revenues                     $      (560 )   $    110,666     $ 110,106     $  498,346     $ 9,856,869     $ 10,355,215

Information with respect to these reportable business segments for the nine months ended September 30, 2021 and 2020 was as follows:





                                                 For the nine months                              For the nine months
                                                 September 30, 2021                                September 30, 2020
                                     Revenues-       Revenues -                       Revenues-       Revenues -
                                       third          related                           third          related
                                      parties          party            Total          parties          party            Total

Revenues:
PRC                                 $ 6,790,616     $ 16,886,287     $ 23,676,903     $  641,316     $ 21,266,710     $ 21,908,026

USA                                      14,086                -           14,086         38,528                -           38,528

Total revenues                      $ 6,804,702     $ 16,886,287     $ 23,690,989     $  679,844     $ 21,266,710     $ 21,946,554
During the three months ended September 30, 2021 and 2020, the revenue from PRC
segment was $101,196 and $10,338,530, respectively, decrease of $10,229,334 or
98.94% due to the decrease demand on Asia market. The decrease in PRC segment
was mainly due to the decrease in revenue from related parties in the amount of
$9,746,203, and the decrease in revenue from third parties in the amount of
483,131.



During the three months ended September 30, 2021 and 2020, the revenue from USA
segment was $910 and $16,685, respectively, decrease of $15,775 or 94.55%. The
decrease in USA segment was due to the decrease in revenue from third parties in
the amount of $15,775 attributable to our China customers' increased oversea
demand.



During the nine months ended September 30, 2021 and 2020, the revenue from PRC
segment was $23,676,903 and $21,908,026, respectively, increase of $1,768,877 or
8.07% due to the increase demand on Asia market. The increase in PRC segment was
mainly due to the increase in revenue from third parties in the amount of
$6,149,300, and partially offset by the decrease in revenue from related parties
in the amount of 4,380,423.



During the nine months ended September 30, 2021 and 2020, the revenue from USA
segment was $14,086 and $38,528, respectively, decrease of $24,442 or 63.44%.
The decrease in USA segment was due to the decrease in revenue from third
parties in the amount of $24,442 attributable to our China customers' decreased
oversea demand.


Liquidity and Capital Resources





Liquidity is the ability of a company to generate funds to support its current
and future operations, satisfy its obligations and otherwise operate on an
ongoing basis. On September 30, 2021 and December 31, 2020, we had cash balances
of $28,453 and $563,792, respectively. These funds are primarily located in
various financial institutions located in China. Our primary uses of cash have
been for the purchase of yew trees, land use rights and yew forest assets.
Additionally, we use cash for employee compensation and working capital. Our
working capital increased by $1,925,307 to $1,389,581 on September 30, 2021,
from working capital of $(535,726) on December 31, 2020.



For the nine months ended September 30, 2021, net cash flow provided by
operating activities was $6,930,855, as compared to net cash flow provided by
operating activities of $12,210,618 for the nine months ended September 30,
2020, a decrease of $5,279,763. Because the exchange rate conversion is
different for the balance sheet and the statements of cash flows, the changes in
assets and liabilities reflected on the statements of cash flows are not
necessarily identical with the comparable changes reflected on the balance
sheets.



For the nine months ended September 30, 2021, net cash flow provided by operating activities of $6,930,855 was primarily attributable to:

? net income of approximately $800,000 adjusted for the add-back of non-cash

items, such as bad debt recovery of approximately $1,800,000, amortization of

land use rights and yew forest assets of approximately $2,000,000, and sale of

yew forest assets as inventory of approximately 8,000,000; and

? changes in operating assets and liabilities, such as an increase in accounts


    receivable of approximately $2,500,000.




  29






For the nine months ended September 30, 2020, net cash flow provided by operating activities of $12,210,618 was primarily attributable to:

? net income of approximately $1,900,000 adjusted for the add-back of non-cash

items, such as sale of yew forest assets as inventory of approximately

8,800,000 and amortization of land use rights and yew forest assets of

approximately $2,000,000; and

? Changes in operating assets and liabilities, such as a decrease in accounts


    receivable of approximately $5,600,000, and an increase in accounts
    receivable-related parties of approximately $6,900,000.




Net cash flow used in investing activities was approximately $7,400,000 for the
nine months ended September 30, 2021. During the nine months ended September 30,
2021, our prepayment in purchase of yew forest assets to related parties
decreased by approximately $4,800,000 and approximately $666,000 government
grants received for afforestation. We also have made payment in approximately
$13,000,000 for purchase of land use right and yew forest assets. Net cash flow
used in investing activities was approximately $11,000,000 for the nine months
ended September 30, 2020. During the nine months ended September 30, 2020, we
have made payment in approximately $11,000,000 for purchase of yew forest
assets.



Net cash flow provided by financing activities was approximately $80,000 for the
nine months ended September 30, 2021 due to proceeds of approximately
$10,500,000 from short-term borrowings and approximately $100,000 from related
parties, and partially offset by repayment of short-term borrowings of
approximately $10,500,000. Net cash flow provided by financing activities was
approximately $420,000 for the nine months ended September 30, 2020 and
consisted of proceeds of $10,900,000 from banks and offset by repayments of
approximately $10,400,000.



We have historically financed our operations and capital expenditures through
cash flows from operations, bank loans and advances from related parties. From
March 2008 to September 2009, we received approximately $2.9 million of proceeds
in the aggregate from offerings and sales of our common stock. Except for the
portion used to pay for professional and other expenses in the U.S., substantial
portions of the proceeds we received through sales of our common stock were
retained in the PRC and used to fund our working capital requirements. As the
PRC government imposes controls on PRC companies' ability to convert RMB into
foreign currencies and the remittance of currency out of China, from time to
time, in order to fund our corporate activities in the U.S., Guifang Qi, our
President and CEO, advanced funds to us in the U.S. and we repaid the amounts
owed to him in RMB in the PRC.



The majority of our funds are maintained in RMB in bank accounts in China. We
receive most of our revenue in the PRC. Under existing PRC foreign exchange
regulations, payments of current account items, including profit distributions,
interest payments and expenditures from trade related transactions, can be made
in foreign currencies by complying with certain procedural requirements.
However, approval from China's State Administration of Foreign Exchange ("SAFE")
or its local counterparts is required where RMB is to be converted into foreign
currency and remitted out of China to pay capital expenses such as the repayment
of loans denominated in foreign currencies. The PRC government may also, at its
discretion, restrict access to foreign currencies for current account
transactions. As of September 30, 2021 and December 31, 2020, approximately
$52.2 million and $50.3 million, respectively, of our net assets are located in
the PRC. If the foreign exchange control system in the PRC prevents us from
obtaining sufficient foreign currency to satisfy our currency demands, we may
not be able to transfer funds deposited within the PRC to fund working capital
requirements in the U.S. or pay any dividends in currencies other than the

RMB,
to our shareholders.


Off-Balance Sheet Arrangements





We have not entered into any financial guarantees or other commitments to
guarantee the payment obligations of any third parties. We have not entered into
any derivative contracts that are indexed to our shares and classified as
shareholder's equity or that are not reflected in our consolidated financial
statements. Furthermore, we do not have any retained or contingent interest in
assets transferred to an unconsolidated entity that serves as credit, liquidity
or market risk support to such entity. We do not have any variable interest in
any unconsolidated entity that provides financing, liquidity, market risk or
credit support to us or engages in leasing, hedging or research and development
services with us.



  30

© Edgar Online, source Glimpses